68 related articles for article (PubMed ID: 6932517)
1. Posttransfusion hepatitis in acute myelogenous leukemia. Effect on survival.
Foon KA; Yale C; Clodfelter K; Gale RP
JAMA; 1980 Oct; 244(16):1806-7. PubMed ID: 6932517
[TBL] [Abstract][Full Text] [Related]
2. Intensive chemotherapy for acute myelogenous leukemia.
Gale RP; Foon KA; Cline MJ; Zighelboim J
Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
4. Progress in acute myelogenous leukemia.
Gale RP
Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
[TBL] [Abstract][Full Text] [Related]
5. Two years' experience in the treatment of acute myeloid leukaemia using a three-drug regimen: daunorubicin, cytosine arabinoside and 6-thioguanine.
McCann SR; Lawlor E; Kinsella IA; Temperley IJ
Ir Med J; 1982 Nov; 75(11):415-7. PubMed ID: 6959984
[No Abstract] [Full Text] [Related]
6. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
[No Abstract] [Full Text] [Related]
7. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
8. D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemia.
Rees JK; Hayhoe FG
Lancet; 1978 Jun; 1(8078):1360-1. PubMed ID: 78123
[No Abstract] [Full Text] [Related]
9. Acute myelogenous leukemia: morphologic classification and response to therapy.
Foon KA; Naiem F; Yale C; Gale RP
Leuk Res; 1979; 3(3):171-3. PubMed ID: 288959
[No Abstract] [Full Text] [Related]
10. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
[No Abstract] [Full Text] [Related]
11. Retrospective analysis of treatment of acute myeloblastic leukemia in patients more than 55 years old.
Barbui T; Bassan R; Chisesi T; Battista R; Cortelazzo S; Rodeghiero F; Capnist G; Viero P; D'Emilio A; Dini E
Acta Haematol; 1982; 67(3):170-4. PubMed ID: 6805203
[No Abstract] [Full Text] [Related]
12. Acute granulocytic leukemia: treatment of the disease.
Weil M; Jacyuillat CI; Gemon-Auclerc MF; Chastang CL; Izrael V; Boiron M; Bernard J
Arch Intern Med; 1976 Dec; 136(12):1389-95. PubMed ID: 1069571
[No Abstract] [Full Text] [Related]
13. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
15. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloblastic leukemia in adults.
Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
[No Abstract] [Full Text] [Related]
17. [Analysis of the therapeutic efficacy and prognostic factors of intensive chemotherapy in 91 patients with acute nonlymphoblastic leukemia].
Bian SG; Hao YS; Wang ZC
Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):22-5, 60. PubMed ID: 2401166
[TBL] [Abstract][Full Text] [Related]
18. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
[TBL] [Abstract][Full Text] [Related]
20. Successful re-induction therapy for acute myelogenous leukemia with cytosine arabinoside and daunorubicin.
Stein RS; Flexner JM
Cancer Treat Rep; 1979; 63(11-12):2123-4. PubMed ID: 294309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
